col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


34 Results       Page 1

 [1] 
Scientific and Technological Research Council of Turkey: TURKISH JOURNAL OF BIOLOGY
  original article Date Title Authors   All Authors
1 [GO] 2022―Aug―24 Development a novel multi-epitope DNA vaccine against human SARS coronavirus-2: an immunoinformatics designing study AFSHIN SAMIMI NEMATI, SAKO MIRZAIE, MOHAMMAD REZA MASOUMIAN, FATEMEH SHEIKHI, MOSTAFA JAMALAN
2 [GO] 2022―May―18 Adoptive T-cell therapies to overcome T cell-dependent immune dysregulations in COVID-19 SEVGİ KALKANLI TAŞ, MERVE SAİDE UZUNOĞLU, AYLİN SEHER UZUNOĞLU, DUYGU KIRKIK, DERYA ALTUNKANAT, NEVİN KALKANLI
3 [GO] 2021―Dec―22 Adoptive T-cell therapies to overcome T cell-dependent immune dysregulations in COVID-19
4 [GO] 2021―Aug―09 Binary-QSAR guided virtual screening of FDA approved drugs and compounds in clinical investigation against SARS-CoV-2 main protease
5 [GO] 2021―Aug―09 The current state of validated small molecules inhibiting SARS-CoV-2 non-structural proteins
6 [GO] 2021―Aug―02 Neuropathy in COVID-19 associated with dysbiosis-related inflammation
7 [GO] 2021―Aug―02 CoronaVac (Sinovac) COVID-19 vaccine-induced molecular changes in healthy human serum by infrared spectroscopy coupled with chemometrics
8 [GO] 2021―Aug―02 Cannabinoids for SARS-CoV-2 and is there evidence of their therapeutic efficacy?
9 [GO] 2021―Aug―02 Host Variations in SARS-CoV-2 Infection
10 [GO] 2021―Aug―02 ß-Carboline alkaloids induce structural plasticity and inhibition of SARS-CoV-2 nsp3 macrodomain more potently than remdesivir metabolite GS-441524: Computational approach
11 [GO] 2021―Aug―02 Genomic Chronicle Of SARS-COV-2: A Mutational Analysis with Over 1 million Genome Sequences
12 [GO] 2021―Jul―29 An update comprehensive review on the status of COVID-19: vaccines, drugs, variants and neurological symptoms
13 [GO] 2021―Jul―20 Novel approaches for COVID-19 diagnosis and treatment: A Nonsystematic Review
14 [GO] 2021―Jul―02 Treatment of COVID-19 Patients with Quercetin in Combination with Vitamin C and Bromelain: A Prospective, Single - Centre, Randomized, Controlled Trial
15 [GO] 2021―Jun―14 Targeting CoV-2 Spike RBD and ACE-2 Interaction with Flavonoids of Anatolian Propolis by in silico and in vitro Studies in Terms of Possible COVID-19 Therapeutics
16 [GO] 2021―Jun―07 Pathogenesis and Treatment of Cytokine Storm in COVID-19
17 [GO] 2021―Jun―07 Determination of the interaction between the receptor binding domain of 2019-nCoV spike protein, TMPRSS2, cathepsin B and cathepsin L and glycosidic and aglycon forms of some flavonols
18 [GO] 2021―May―14 The potential use of Drosophila as an in vivo model organism for COVID-19-related research: A review
19 [GO] 2021―May―09 In silico drug repositioning against human NRP1 to block SARS-CoV-2 host entry
20 [GO] 2021―Jan―03 Current mutatome of SARS-CoV-2 in Turkey reveals mutations of interest
21 [GO] 2020―Jun―12 SARS-CoV-2 Isolation and Propagation from Turkish COVID-19 patients
22 [GO] 2020―Jun―12 Interaction of certain monoterpenoid hydrocarbons with the receptor-binding domain of 2019 novel coronavirus (2019-nCoV), transmembrane serine protease 2 (TMPRSS2), cathepsin B, and cathepsin L (CatB/L) and their pharmacokinetic properties
23 [GO] 2020―Jun―12 An updated analysis of variations in SARS-CoV-2 genome
24 [GO] 2020―Jun―12 Integration of transcriptomic profile of SARS-CoV-2 infected normal human bronchial epithelial cells with metabolic and protein-protein interaction networks
25 [GO] 2020―Jun―12 SARS-CoV-2 neutralizing antibody development strategies
26 [GO] 2020―Jun―09 An Insight into the Epitope-Based Peptide Vaccine Design Strategy and Studies Against COVID-19
27 [GO] 2020―Jun―09 Gut-lung axis and dysbiosis in COVID-19
28 [GO] 2020―Jun―09 Potentials of Plant-based Substance to Inhabit and Probable Cure for the COVID-19
29 [GO] 2020―Jun―09 Phylogenetic Analysis of SARS-CoV-2 Genomes in Turkey
30 [GO] 2020―Jun―09 Identification of the nucleotide substitutions in 62 SARS-CoV-2 sequences from Turkey
31 [GO] 2020―Jun―09 Virtual drug repurposing study against SARS-CoV-2 TMPRSS2 target
32 [GO] 2020―Jun―09 Biosafety and Biosecurity Approaches to Restrain/Contain and Counter SARS-CoV-2/COVID-19 Pandemic: A Rapid-Review
33 [GO] 2020―May―18 COVID-19: Current Knowledge, Disease Potential, Prevention and Clinical Advances
34 [GO] 2020―May―05 Mesenchymal stem cell derived extracellular vesicles: promising immunomodulators against autoimmune, autoinflammatory disorders and SARS-CoV-2 infection
 [1] 

34 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.247 sec